TRDA
Price
$7.17
Change
+$0.19 (+2.73%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
271.75M
28 days until earnings call
TRVI
Price
$5.85
Change
-$0.10 (-1.68%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
712.87M
30 days until earnings call
Interact to see
Advertisement

TRDA vs TRVI

Header iconTRDA vs TRVI Comparison
Open Charts TRDA vs TRVIBanner chart's image
Entrada Therapeutics
Price$7.17
Change+$0.19 (+2.73%)
Volume$4.36K
Capitalization271.75M
Trevi Therapeutics
Price$5.85
Change-$0.10 (-1.68%)
Volume$25.34K
Capitalization712.87M
TRDA vs TRVI Comparison Chart in %
Loading...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TRDA vs. TRVI commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRDA is a StrongBuy and TRVI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (TRDA: $7.16 vs. TRVI: $5.86)
Brand notoriety: TRDA and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TRDA: 120% vs. TRVI: 69%
Market capitalization -- TRDA: $271.75M vs. TRVI: $712.87M
TRDA [@Biotechnology] is valued at $271.75M. TRVI’s [@Biotechnology] market capitalization is $712.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TRDA’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • TRDA’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, both TRDA and TRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TRDA’s TA Score shows that 5 TA indicator(s) are bullish while TRVI’s TA Score has 3 bullish TA indicator(s).

  • TRDA’s TA Score: 5 bullish, 3 bearish.
  • TRVI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than TRVI.

Price Growth

TRDA (@Biotechnology) experienced а +0.70% price change this week, while TRVI (@Biotechnology) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

TRDA is expected to report earnings on Nov 11, 2025.

TRVI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($713M) has a higher market cap than TRDA($272M). TRVI YTD gains are higher at: 44.417 vs. TRDA (-58.589). TRDA has higher annual earnings (EBITDA): 7.89M vs. TRVI (-47.23M). TRDA has more cash in the bank: 383M vs. TRVI (103M). TRVI has less debt than TRDA: TRVI (957K) vs TRDA (57M). TRDA has higher revenues than TRVI: TRDA (172M) vs TRVI (0).
TRDATRVITRDA / TRVI
Capitalization272M713M38%
EBITDA7.89M-47.23M-17%
Gain YTD-58.58944.417-132%
P/E Ratio12.34N/A-
Revenue172M0-
Total Cash383M103M372%
Total Debt57M957K5,956%
FUNDAMENTALS RATINGS
TRVI: Fundamental Ratings
TRVI
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TRDATRVI
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNBIX20.39N/A
N/A
Manning & Napier Pro-Blend Extnd Term I
LIOTX10.04N/A
N/A
Issachar I
ETLNX15.27N/A
N/A
Eventide Large Cap Focus N
HGOCX61.20-0.37
-0.60%
Hartford Growth Opportunities C
RSGGX25.87-0.25
-0.96%
Victory RS Global A

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with PTGX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
N/A
PTGX - TRVI
43%
Loosely correlated
-2.31%
BIESF - TRVI
43%
Loosely correlated
N/A
GOSS - TRVI
33%
Loosely correlated
+0.81%
MLYS - TRVI
31%
Poorly correlated
-6.95%
QURE - TRVI
30%
Poorly correlated
-0.76%
More